PDS Biotechnology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PDSB and other ETFs, options, and stocks.About PDSB
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection.
CEOFrank K. Bedu-Addo
CEOFrank K. Bedu-Addo
Employees24
Employees24
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2005
Founded2005
Employees24
Employees24
PDSB Key Statistics
Market cap55.99M
Market cap55.99M
Price-Earnings ratio-1.42
Price-Earnings ratio-1.42
Dividend yield—
Dividend yield—
Average volume500.45K
Average volume500.45K
High today$1.34
High today$1.34
Low today$1.21
Low today$1.21
Open price$1.31
Open price$1.31
Volume648.67K
Volume648.67K
52 Week high$4.42
52 Week high$4.42
52 Week low$0.8505
52 Week low$0.8505
People also own
Based on the portfolios of people who own PDSB. This list is generated using Robinhood data, and it’s not a recommendation.